TrialJournal of diabetes science and technology2024

Two-Way Crossover Phase 1 Bioequivalence and Safety Studies in Healthy Adults for a Ready-to-Use, Room-Temperature, Liquid-Stable Glucagon Administered by Autoinjector, Prefilled Syringe, or Vial and Syringe.

M Khaled Junaidi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.